Back

Major adverse cardiovascular events (MACE) are reduced in testosterone-treated vs. untreated hypogonadal men: real-life evidence from a controlled registry study

26 August 2017 (00:00 - 00:00)
Organised by:
Congress Presentation Part of: Poster session 7 - Prevention general Primary cardiovascular prevention: interventions and outcomes ESC Premium Access ESC Congress 2017

About the speaker

Photo
Professor Farid Saad

Bayer AG, Berlin (Germany)

27 More presentations in this session

Presentation thumbnail
Enhanced cardiovascular susceptibility to air pollution: A 4 years echocardiographic study of pulmonary circulation.
Professor J. Argacha (Brussels, BE)
Abstract Slides
Presentation thumbnail
Systemic inflammatory response in chronic venous disorders and their clinical relevance in the general population.
Doctor N. Arnold (Hamburg, DE)
Abstract
Presentation thumbnail
The hemoglobin A1C and creatinine are associated with coronary calcium score for female but not male in a general low risk population
Doctor J. Wu (Toufen, TW)
Abstract Slides
Presentation thumbnail
ABCA1 gene polymorphism InsG319 prevents the development of impaired glucose tolerance in young and middle-aged women
Professor S. Boldueva (Saint Petersburg, RU)
Abstract
Presentation thumbnail
Andexanet alfa reduces betrixaban-induced blood loss in a rabbit liver laceration model of acute bleeding.
Doctor P. Conley (South San Francisco, US)
Abstract

Access the full session

Session thumbnail
Poster session 7 - Prevention general

The Event

Event poster

ESC Congress 2017

26 August - 30 August 2017

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources